-
Most Recent
Search Results
240 results for ELN
Why Eli Lilly Could Be a Lottery Stock Pick
If Eli Lilly is successful in delaying the progression of Alzheimer’s disease with its experimental drug, it could make Lipitor look like a mid-sized product.…
Amazon’s Globalstar Acquisition Changes More Than Satellite Internet
Amazon’s Globalstar acquisition signals a shift toward satellite internet – and orbital compute: the next frontier of AI infrastructure.
No Payday In Sight for Alzheimer’s Drug Stocks
At best, the drugs on the market are stopgap measures. They can’t cure the disease.
Homes Are Where the Gains Are — Thursday’s IP Market Recap
Better-than-expected housing reports push the S&P back into the black.
10 Big Pharma Stocks to Buy
Pharmaceutical stocks and drugmakers are theoretically recession-proof businesses. Still, not all pharma companies are created equal. Here are 10 clear winners
Lilly Study Could Sink Prospects for Alzheimer’s Treatments
Eli Lilly’s drug study failure raises questions about the safety of its Alzheimer’s treatment, but will rival Bristol-Myers have success?
Alkermes Looks to Enter Biotech Big Leagues
CEO orchestrates a transformation that could leave the company poised for further growth.
Tesla Vs. Vertiv – Which One Should You Buy After Earnings?
Tesla, Inc. (TSLA) and Vertiv Holdings Co. (VRT) both released results yesterday – and in doing so, revealed exactly where investors are still getting AI…
The $48 Billion AI IPO Squeeze Wall Street Isn’t Warning You About
OpenAI, SpaceX, and Anthropic IPOs are coming soon. Learn how to invest before billions in forced buying hits the market.
Coffee Holding Co. Percolates to New 52-week high
thanks to strong earnings, java giant Coffee Holding Co. (NASDAQ:JVA) stock is at a new 52 week high. World Wrestling Entertainment NYSE:WWE stock, however, is…
Biotech Royalty Paying 9% Dividend Yield
Technology permitting the deployment of animal-derived antibodies in human patients feeds PDL BioPharma’s rich royalty stream.
If Novartis’ MS Drug Falters, Biogen Will Gain
After the deaths of 11 people who were taking the drug, concerns that Gilenya may cause heart problems has hit NVS hard, ending the stock’s…
Bank of America Falls Below $5 — Monday’s IP Market Recap
BofA’s latest slide continues, leading big banks like Citi, JPMorgan, Goldman and Wells Fargo lower. Also, AT&T announces it will end its bid for T-Mobile…
Merger Monday: Another Win for Healthcare Stocks
Omnicom and Saks made M&A ripples, but Elan’s $6.7B sale to Perrigo fortifies the case for more deals in the healthcare sector.
Stop Asking Where the Market Is Headed
In today’s Saturday Digest, Keith Kaplan explains why some of the most successful investors in history – including legendary hedge fund manager Jim Simons –…
John Paulson Loves Pianos, Hates Financials
John Paulson’s hedge fund Paulson & Co. didn’t just buy piano-maker Steinway this week — it also filed its 13F. Here’s everything you need to…
The Hidden “Thumbprints” Behind Big Stock Moves
In September 1995, a philosophy professor read a manifesto in The Washington Post and unmasked a killer…
3 Powerful ETFs to Buy to Retire on Easy Street
Invest in retirement ETFs managed by reputable institutions, ensuring steady income through dividends and share price gains.
Stop Guessing the Market. Use AI Trading Signals Instead
Forget forecasts. AI trading signals identify repeatable patterns that drive profits in any market environment.
Q3’s Rising Stars: 8 Dividend Stocks for Your Must-Watch List
These seven dividend stocks to watch can enhance your portfolio’s return by providing both growth and income.
Market Analysis – Warning: Market May Cause Indigestion
If you plan to buy stocks now, you had better order a case of antacids to go along with your Wall Street Journal.
The Question Every Investor Gets Wrong
Keith is joining us today to explain how his team is using AI to uncover these kinds of “signals” across thousands of stocks. It’s the…
5 – 10 of 240 results
